| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.22e-07 | 49 | 175 | 7 | GO:0140359 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 RAP1GAP DDX12P ABCA4 TDRD9 ABCA13 RAB42 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 GUF1 MTIF2 EIF4A1 MOV10L1 MACF1 RASL11B ATP13A3 RASL10B DNAH9 DDX11L8 | 3.20e-07 | 775 | 175 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 DDX12P ABCA4 TDRD9 ABCA13 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 EIF4A1 MOV10L1 MACF1 ATP13A3 DNAH9 DDX11L8 | 3.63e-07 | 441 | 175 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 RAP1GAP DDX12P ABCA4 TDRD9 ABCA13 RAB42 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 GUF1 MTIF2 EIF4A1 MOV10L1 MACF1 RASL11B ATP13A3 RASL10B DNAH9 DDX11L8 | 1.26e-06 | 839 | 175 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 RAP1GAP DDX12P ABCA4 TDRD9 ABCA13 RAB42 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 GUF1 MTIF2 EIF4A1 MOV10L1 MACF1 RASL11B ATP13A3 RASL10B DNAH9 DDX11L8 | 1.28e-06 | 840 | 175 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 RAP1GAP DDX12P ABCA4 TDRD9 ABCA13 RAB42 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 GUF1 MTIF2 EIF4A1 MOV10L1 MACF1 RASL11B ATP13A3 RASL10B DNAH9 DDX11L8 | 1.28e-06 | 840 | 175 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | triplex DNA binding | 2.63e-06 | 4 | 175 | 3 | GO:0045142 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.31e-06 | 109 | 175 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 5.51e-06 | 78 | 175 | 7 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 6.53e-06 | 80 | 175 | 7 | GO:0008186 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 DDX12P ABCA4 TDRD9 ABCA13 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 DNAH1 EIF4A1 MOV10L1 MACF1 ATP13A3 DNAH9 DDX11L8 | 7.94e-06 | 614 | 175 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA1 ABCA4 ABCA13 PKD2L1 SLC10A3 GRIK4 BCS1L ABCA7 SLC4A3 SLC40A1 CHRNA1 ABCC6 ABCB1 CUL5 SLC32A1 ATP1B4 SLC30A5 SLC12A1 CLCNKA CLCNKB PKD1 KCNK2 SLC7A5 ATP13A3 SLC7A5P1 SLC23A1 | 1.31e-05 | 1180 | 175 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA1 ABCA4 ABCA13 SLC10A3 BCS1L ABCA7 SLC4A3 ABCC6 ABCB1 SLC32A1 SLC30A5 SLC12A1 SLC7A5 ATP13A3 SLC23A1 | 2.09e-05 | 477 | 175 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 NAALADL1 DSC1 DSG1 PKD2L1 ADGRV1 ITIH1 CEMIP2 STAB1 EPS15L1 DUOX1 FAT1 HMCN2 HMCN1 NRXN1 OTOF MACF1 PLCB3 CDH15 | 3.31e-05 | 749 | 175 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 3.59e-05 | 8 | 175 | 3 | GO:0090554 | |
| GeneOntologyMolecularFunction | transporter activity | ABCA1 ABCA4 ABCA13 PKD2L1 SLC10A3 GRIK4 BCS1L ABCA7 SLC4A3 SLC40A1 CHRNA1 ABCC6 ABCB1 CUL5 SLC32A1 ATP1B4 SLC30A5 SLC12A1 CLCNKA CLCNKB PKD1 KCNK2 SLC7A5 ATP13A3 SLC7A5P1 SLC23A1 | 5.86e-05 | 1289 | 175 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | apolipoprotein A-I receptor activity | 7.64e-05 | 2 | 175 | 2 | GO:0034188 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 9.90e-05 | 28 | 175 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.79e-04 | 178 | 175 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 2.28e-04 | 3 | 175 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CNTN4 DOCK9 OBSCN ITGA8 LAMA5 ITGAL CEMIP2 HNRNPK POSTN EPS15L1 F11R NRXN1 MACF1 PLCB3 CDH15 | 2.65e-04 | 599 | 175 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | floppase activity | 3.41e-04 | 16 | 175 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 4.53e-04 | 4 | 175 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 4.90e-04 | 18 | 175 | 3 | GO:0003688 | |
| GeneOntologyMolecularFunction | helicase activity | 4.95e-04 | 158 | 175 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 6.76e-04 | 20 | 175 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 7.58e-04 | 47 | 175 | 4 | GO:0051539 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.03e-03 | 51 | 175 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | PKD2L1 SLC10A3 GRIK4 SLC4A3 SLC40A1 ABCC6 CUL5 SLC32A1 ATP1B4 SLC30A5 SLC12A1 CLCNKA CLCNKB PKD1 KCNK2 SLC23A1 | 1.06e-03 | 758 | 175 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | DDX12P TDRD9 CDKAL1 DHX30 DHX9 EIF4A1 MOV10L1 TRMT61B CNOT1 DDX11L8 PUS7 | 1.16e-03 | 417 | 175 | 11 | GO:0140098 |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 1.47e-03 | 56 | 175 | 4 | GO:0016763 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 1.56e-03 | 7 | 175 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | PKD2L1 SLC10A3 GRIK4 SLC4A3 SLC40A1 CHRNA1 CUL5 SLC32A1 SLC30A5 SLC12A1 CLCNKA CLCNKB PKD1 KCNK2 ATP13A3 SLC23A1 | 1.69e-03 | 793 | 175 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 2.04e-03 | 29 | 175 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.14e-03 | 62 | 175 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.15e-03 | 321 | 175 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | hyalurononglucosaminidase activity | 2.64e-03 | 9 | 175 | 2 | GO:0004415 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.64e-03 | 9 | 175 | 2 | GO:0090556 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 8.42e-06 | 16 | 175 | 4 | GO:0007158 | |
| GeneOntologyCellularComponent | apical part of cell | NAALADL1 DSG1 ITGA8 ABCA7 ABCC6 ABCB1 DUOX1 FAT1 SLC30A5 SLC12A1 CLCNKA OTOF CSPG4 KCNK2 SLC7A5 SLC23A1 | 3.73e-05 | 592 | 174 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | NAALADL1 DSG1 ABCA7 ABCC6 ABCB1 DUOX1 FAT1 SLC30A5 SLC12A1 CLCNKA CSPG4 KCNK2 SLC7A5 SLC23A1 | 6.02e-05 | 487 | 174 | 14 | GO:0016324 |
| GeneOntologyCellularComponent | cell surface | ABCA1 ITGA8 PKD2L1 IL17RC ADGRV1 ITGAL ABCA7 SLC4A3 CHRNA1 ABCB1 PHB1 SLC32A1 DUOX1 SLC12A1 NRXN1 CSPG4 UNC5C VAMP1 PKD1 KCNK2 SLC7A5 IGSF3 | 1.44e-04 | 1111 | 174 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | collagen type VI trimer | 2.06e-04 | 3 | 174 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic active zone membrane | 2.06e-04 | 3 | 174 | 2 | GO:0098891 | |
| GeneOntologyCellularComponent | collagen beaded filament | 2.06e-04 | 3 | 174 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | cell projection membrane | ITGA8 PKD2L1 ADGRV1 ABCA7 ADCY3 CASK CSPG4 PKD1 SNTG1 MACF1 SLC7A5 TCTN2 | 2.74e-04 | 431 | 174 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | neuromuscular junction | 3.52e-04 | 112 | 174 | 6 | GO:0031594 | |
| HumanPheno | Fetal polyuria | 2.18e-05 | 12 | 77 | 4 | HP:0001563 | |
| HumanPheno | Abnormal urine chloride concentration | 3.25e-05 | 5 | 77 | 3 | HP:0012600 | |
| HumanPheno | Hyperchloriduria | 3.25e-05 | 5 | 77 | 3 | HP:0002914 | |
| HumanPheno | Abnormal circulating prostaglandin circulation | 6.43e-05 | 6 | 77 | 3 | HP:0011023 | |
| HumanPheno | Hyperprostaglandinuria | 6.43e-05 | 6 | 77 | 3 | HP:0003527 | |
| Domain | ABC_A | 2.62e-06 | 12 | 163 | 4 | IPR026082 | |
| Domain | ABC_tran | 3.65e-06 | 48 | 163 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.65e-06 | 48 | 163 | 6 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 4.13e-06 | 49 | 163 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 4.66e-06 | 50 | 163 | 6 | IPR003439 | |
| Domain | VWFA | 7.44e-06 | 82 | 163 | 7 | PS50234 | |
| Domain | - | ABCA1 ABCA4 TDRD9 ABCA13 RAB42 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 DNAH1 CASK GUF1 MTIF2 EIF4A1 MOV10L1 RASL11B RASL10B DNAH9 | 8.22e-06 | 746 | 163 | 20 | 3.40.50.300 |
| Domain | VWA | 8.74e-06 | 84 | 163 | 7 | SM00327 | |
| Domain | - | 1.97e-05 | 95 | 163 | 7 | 2.60.120.200 | |
| Domain | VWF_A | 2.57e-05 | 99 | 163 | 7 | IPR002035 | |
| Domain | ABC_transporter_CS | 3.12e-05 | 42 | 163 | 5 | IPR017871 | |
| Domain | AAA | 3.90e-05 | 144 | 163 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 3.90e-05 | 144 | 163 | 8 | IPR003593 | |
| Domain | P-loop_NTPase | ABCA1 ABCA4 TDRD9 ABCA13 RAB42 BCS1L ABCA7 ABCC6 DHX30 ABCB1 DHX9 DNAH1 CASK GUF1 MTIF2 EIF4A1 MOV10L1 RASL11B RASL10B DNAH9 | 5.13e-05 | 848 | 163 | 20 | IPR027417 |
| Domain | TF_IF2_bacterial-like | 7.57e-05 | 2 | 163 | 2 | IPR000178 | |
| Domain | Cl_channel-K | 7.57e-05 | 2 | 163 | 2 | IPR002250 | |
| Domain | VWA | 1.27e-04 | 56 | 163 | 5 | PF00092 | |
| Domain | ARM-like | DOCK2 NBEA API5 EFR3A PPP2R1A TELO2 MROH2B HEATR5B NIPBL XPOT | 1.34e-04 | 270 | 163 | 10 | IPR011989 |
| Domain | ARM-type_fold | DOCK2 DOCK9 NBEA API5 EFR3A PPP2R1A TELO2 MROH2B HEATR5B NIPBL XPOT | 1.98e-04 | 339 | 163 | 11 | IPR016024 |
| Domain | GADD45 | 2.26e-04 | 3 | 163 | 2 | IPR024824 | |
| Domain | IGc2 | 2.27e-04 | 235 | 163 | 9 | SM00408 | |
| Domain | Ig_sub2 | 2.27e-04 | 235 | 163 | 9 | IPR003598 | |
| Domain | Ig_I-set | 2.68e-04 | 190 | 163 | 8 | IPR013098 | |
| Domain | I-set | 2.68e-04 | 190 | 163 | 8 | PF07679 | |
| Domain | LAM_G_DOMAIN | 3.27e-04 | 38 | 163 | 4 | PS50025 | |
| Domain | CBS | 3.36e-04 | 16 | 163 | 3 | SM00116 | |
| Domain | Laminin_G_2 | 4.00e-04 | 40 | 163 | 4 | PF02210 | |
| Domain | Neural_cell_adh | 4.49e-04 | 4 | 163 | 2 | IPR009138 | |
| Domain | FAS1 | 4.49e-04 | 4 | 163 | 2 | SM00554 | |
| Domain | G2F | 4.49e-04 | 4 | 163 | 2 | PF07474 | |
| Domain | FAS1_domain | 4.49e-04 | 4 | 163 | 2 | IPR000782 | |
| Domain | G8_domain | 4.49e-04 | 4 | 163 | 2 | IPR019316 | |
| Domain | G8 | 4.49e-04 | 4 | 163 | 2 | PS51484 | |
| Domain | G8 | 4.49e-04 | 4 | 163 | 2 | SM01225 | |
| Domain | NIDOGEN_G2 | 4.49e-04 | 4 | 163 | 2 | PS50993 | |
| Domain | GFP | 4.49e-04 | 4 | 163 | 2 | IPR009017 | |
| Domain | PC1 | 4.49e-04 | 4 | 163 | 2 | IPR000434 | |
| Domain | G8 | 4.49e-04 | 4 | 163 | 2 | PF10162 | |
| Domain | - | 4.49e-04 | 4 | 163 | 2 | 2.30.180.10 | |
| Domain | FAS1 | 4.49e-04 | 4 | 163 | 2 | PS50213 | |
| Domain | Fasciclin | 4.49e-04 | 4 | 163 | 2 | PF02469 | |
| Domain | G2_nidogen/fibulin_G2F | 4.49e-04 | 4 | 163 | 2 | IPR006605 | |
| Domain | - | 4.72e-04 | 74 | 163 | 5 | 3.40.50.410 | |
| Domain | HA2 | 4.84e-04 | 18 | 163 | 3 | SM00847 | |
| Domain | HA2 | 4.84e-04 | 18 | 163 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 4.84e-04 | 18 | 163 | 3 | IPR007502 | |
| Domain | IGv | 5.02e-04 | 75 | 163 | 5 | SM00406 | |
| Domain | LamG | 5.78e-04 | 44 | 163 | 4 | SM00282 | |
| Domain | CBS_dom | 6.67e-04 | 20 | 163 | 3 | IPR000644 | |
| Domain | CBS | 6.67e-04 | 20 | 163 | 3 | PF00571 | |
| Domain | CBS | 6.67e-04 | 20 | 163 | 3 | PS51371 | |
| Domain | FerI | 7.44e-04 | 5 | 163 | 2 | SM01202 | |
| Domain | FerB | 7.44e-04 | 5 | 163 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 7.44e-04 | 5 | 163 | 2 | IPR012561 | |
| Domain | Ferlin_C | 7.44e-04 | 5 | 163 | 2 | PF16165 | |
| Domain | Ferlin_C | 7.44e-04 | 5 | 163 | 2 | IPR032362 | |
| Domain | FerIin_dom | 7.44e-04 | 5 | 163 | 2 | IPR012968 | |
| Domain | FerI | 7.44e-04 | 5 | 163 | 2 | PF08151 | |
| Domain | FerB | 7.44e-04 | 5 | 163 | 2 | PF08150 | |
| Domain | - | 7.54e-04 | 222 | 163 | 8 | 1.25.10.10 | |
| Domain | GroES-like | 1.15e-03 | 24 | 163 | 3 | IPR011032 | |
| Domain | Cadherin_C | 1.30e-03 | 25 | 163 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.30e-03 | 25 | 163 | 3 | IPR000233 | |
| Domain | PKD | 1.54e-03 | 7 | 163 | 2 | PF00801 | |
| Domain | Desmosomal_cadherin | 1.54e-03 | 7 | 163 | 2 | IPR009122 | |
| Domain | Elp3 | 1.54e-03 | 7 | 163 | 2 | SM00729 | |
| Domain | Elp3/MiaB/NifB | 1.54e-03 | 7 | 163 | 2 | IPR006638 | |
| Domain | Laminin_G | 1.64e-03 | 58 | 163 | 4 | IPR001791 | |
| Domain | Catenin_binding_dom | 2.02e-03 | 29 | 163 | 3 | IPR027397 | |
| Domain | - | 2.02e-03 | 29 | 163 | 3 | 4.10.900.10 | |
| Domain | Pectin_lyase_fold/virulence | 2.05e-03 | 8 | 163 | 2 | IPR011050 | |
| Domain | VIT | 2.05e-03 | 8 | 163 | 2 | PF08487 | |
| Domain | VIT | 2.05e-03 | 8 | 163 | 2 | SM00609 | |
| Domain | Cl-channel_core | 2.62e-03 | 9 | 163 | 2 | IPR014743 | |
| Domain | rSAM | 2.62e-03 | 9 | 163 | 2 | IPR007197 | |
| Domain | - | 2.62e-03 | 9 | 163 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 2.62e-03 | 9 | 163 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 2.62e-03 | 9 | 163 | 2 | IPR001807 | |
| Domain | Radical_SAM | 2.62e-03 | 9 | 163 | 2 | PF04055 | |
| Domain | PKD/Chitinase_dom | 2.62e-03 | 9 | 163 | 2 | IPR022409 | |
| Domain | PKD | 2.62e-03 | 9 | 163 | 2 | SM00089 | |
| Domain | Cadherin_CS | 2.68e-03 | 109 | 163 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 3.13e-03 | 113 | 163 | 5 | PS00232 | |
| Domain | Cadherin | 3.13e-03 | 113 | 163 | 5 | PF00028 | |
| Domain | ConA-like_dom | 3.15e-03 | 219 | 163 | 7 | IPR013320 | |
| Domain | GPS | 3.20e-03 | 34 | 163 | 3 | SM00303 | |
| Domain | VIT | 3.25e-03 | 10 | 163 | 2 | PS51468 | |
| Domain | VIT | 3.25e-03 | 10 | 163 | 2 | IPR013694 | |
| Domain | CADHERIN_2 | 3.26e-03 | 114 | 163 | 5 | PS50268 | |
| Domain | - | 3.26e-03 | 114 | 163 | 5 | 2.60.40.60 | |
| Domain | HEAT_REPEAT | 3.28e-03 | 70 | 163 | 4 | PS50077 | |
| Domain | CA | 3.38e-03 | 115 | 163 | 5 | SM00112 | |
| Domain | GPS | 3.48e-03 | 35 | 163 | 3 | PF01825 | |
| Domain | Cadherin-like | 3.51e-03 | 116 | 163 | 5 | IPR015919 | |
| Domain | GPS | 3.77e-03 | 36 | 163 | 3 | PS50221 | |
| Domain | Cadherin | 3.77e-03 | 118 | 163 | 5 | IPR002126 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.81e-03 | 73 | 163 | 4 | IPR011545 | |
| Domain | DEAD | 3.81e-03 | 73 | 163 | 4 | PF00270 | |
| Domain | GFP-like | 3.95e-03 | 11 | 163 | 2 | IPR023413 | |
| Domain | DHR-1_domain | 3.95e-03 | 11 | 163 | 2 | IPR027007 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.61e-06 | 44 | 135 | 6 | M11911 | |
| Pubmed | CNTN4 DCHS2 LURAP1 RAP1GAP NCAM2 NBEA JAKMIP3 ODF2 SLC4A3 HNRNPK DHX30 CASK STAB1 CCDC13 GUF1 RBM22 EPS15L1 OTOF SUPT5H MTIF2 EIF4A1 NEMF PKD1 MACF1 TMEM131 NIPBL XPOT | 3.44e-10 | 1285 | 175 | 27 | 35914814 | |
| Pubmed | Polarized targeting of neurexins to synapses is regulated by their C-terminal sequences. | 1.25e-07 | 3 | 175 | 3 | 19036990 | |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 24097981 | ||
| Pubmed | RAP1GAP ELP1 CEMIP2 CEMIP CUL5 PARP4 SLC30A5 WDR11 SUPT5H MTIF2 ARHGEF1 EIF4A1 NEMF PLCB3 DDX11L8 RIC1 | 2.16e-07 | 650 | 175 | 16 | 38777146 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK2 ELP1 API5 HNRNPK DHX9 STAB1 PPP2R1A PARP4 ARHGEF1 EIF4A1 MACF1 CNOT1 NIPBL KDM1A CPSF7 | 2.95e-07 | 582 | 175 | 15 | 20467437 |
| Pubmed | KRT19 NBEA GPATCH4 CEMIP2 HNRNPK DHX9 CASK PHB1 EPS15L1 FAT1 VPS52 SLC30A5 WDR11 UNC5C SLC7A5 RPL9 IGSF3 | 4.63e-07 | 777 | 175 | 17 | 35844135 | |
| Pubmed | DOCK2 AMFR DOCK9 API5 ITGAL ADCY3 CDKAL1 HNRNPK DHX9 PHB1 PARP4 EPS15L1 INTS5 WDR11 EIF4A1 SLC7A5 ATP13A3 HEATR5B CNOT1 RPL9 CPSF7 | 4.93e-07 | 1168 | 175 | 21 | 19946888 | |
| Pubmed | ELP1 BCS1L SIRT1 CDKAL1 CEMIP2 DHX30 DHX9 CASK PHB1 EFR3A GUF1 MRPL15 WDR11 TELO2 DNAJC15 MTIF2 ANKRD11 MACF1 SLC7A5 TMEM131 SEMA6A DCXR PUS7 RPL9 | 4.95e-07 | 1487 | 175 | 24 | 33957083 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 6.45e-07 | 33 | 175 | 5 | 18480165 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 IRS4 ISOC1 HNRNPK DHX9 DNAH1 PHB1 GUF1 PPP2R1A DUOX1 EIF4A1 MOV10L1 MACF1 CNOT1 DCXR RPL9 XPOT | 7.79e-07 | 807 | 175 | 17 | 30575818 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IRS4 DSG1 ELP1 HNRNPK DHX30 ABCB1 DHX9 PHB1 PPP2R1A F11R SUPT5H EIF4A1 MACF1 HEATR5B CNOT1 NIPBL KDM1A RPL9 CPSF7 | 1.13e-06 | 1024 | 175 | 19 | 24711643 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | IRS4 DDX12P DSC1 DSG1 ELP1 CDKAL1 HNRNPK DHX30 DHX9 PHB1 PPP2R1A WDR11 TELO2 EIF4A1 SLC7A5 CNOT1 DCXR KDM1A RPL9 XPOT CPSF7 | 1.59e-06 | 1257 | 175 | 21 | 37317656 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GOLM2 OBSCN NCAM2 ANKMY1 ADGRV1 BCAR1 ADCY3 DNAH1 CASK CUL5 EPS15L1 PWWP2B WDR11 NEMF ANKRD11 MACF1 SEMA6A RIMS1 PRKAG2 CNOT1 ADGRD1 RIC1 CDH15 | 1.84e-06 | 1489 | 175 | 23 | 28611215 |
| Pubmed | 2.24e-06 | 167 | 175 | 8 | 22159717 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DSG1 ELP1 ISOC1 GPATCH4 YY1 HNRNPK DHX30 DHX9 PHB1 PPP2R1A RBM22 DNAJC15 ARHGEF1 EIF4A1 NEMF MACF1 SLC7A5 PLCB3 NIPBL PUS7 RPL9 XPOT | 2.83e-06 | 1415 | 175 | 22 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IRS4 DSC1 DSG1 ELP1 GPATCH4 API5 HNRNPK DHX30 DHX9 PHB1 PPP2R1A RBM22 SUPT5H EIF4A1 NEMF SLC7A5 CNOT1 NIPBL KDM1A RPL9 XPOT CPSF7 | 3.17e-06 | 1425 | 175 | 22 | 30948266 |
| Pubmed | IRS4 ELP1 ISOC1 API5 SIRT1 HNRNPK DHX30 DHX9 PHB1 CUL5 PPP2R1A RBM22 HMCN2 MRPL15 WDR11 SUPT5H EIF4A1 SLC7A5 ASB4 KDM1A RPL9 | 4.06e-06 | 1335 | 175 | 21 | 29229926 | |
| Pubmed | 4.10e-06 | 128 | 175 | 7 | 30995482 | ||
| Pubmed | Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency. | 4.32e-06 | 7 | 175 | 3 | 34499620 | |
| Pubmed | Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney. | 4.32e-06 | 7 | 175 | 3 | 11423561 | |
| Pubmed | IRS4 ELP1 API5 HNRNPK DHX30 DHX9 PHB1 PPP2R1A TELO2 CNOT1 KDM1A RPL9 XPOT CPSF7 | 4.81e-06 | 638 | 175 | 14 | 33239621 | |
| Pubmed | AMFR IRS4 ELP1 BCS1L CASK PPP2R1A VPS52 WDR11 TELO2 SUPT5H CNOT1 KDM1A XPOT | 5.83e-06 | 560 | 175 | 13 | 35241646 | |
| Pubmed | ELP1 ITGAL HNRNPK DHX30 DHX9 PHB1 WDR11 SUPT5H NEMF NADK SLC7A5 PUS7 XPOT CPSF7 | 6.26e-06 | 653 | 175 | 14 | 33742100 | |
| Pubmed | ABCA4 CEMIP2 DHX30 PARP4 WDR11 ARHGEF1 CSPG4 SLC7A5 PLCB3 CNOT1 | 6.49e-06 | 325 | 175 | 10 | 36168628 | |
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 6.88e-06 | 8 | 175 | 3 | 12766770 | |
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 6.88e-06 | 8 | 175 | 3 | 24563484 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DOCK9 CEMIP2 ABCB1 CASK EFR3A FAT1 F11R CSPG4 SLC7A5 PLCB3 SEMA6A ATP13A3 IGSF3 | 6.91e-06 | 569 | 175 | 13 | 30639242 |
| Pubmed | 7.61e-06 | 197 | 175 | 8 | 31620119 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 DOCK9 OBSCN NBEA PHB1 PPP2R1A ANKRD11 CNOT1 KDM1A RIC1 XPOT CPSF7 | 9.09e-06 | 497 | 175 | 12 | 36774506 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GADD45B DOCK9 OBSCN LAMA5 SLC10A3 ABCA7 DHX30 EPS15L1 FAT1 INTS5 PWWP2B CSPG4 PKD1 ANKRD11 NADK SLC7A5 RIC1 IGSF3 | 1.30e-05 | 1105 | 175 | 18 | 35748872 |
| Pubmed | 1.46e-05 | 10 | 175 | 3 | 12724416 | ||
| Pubmed | GPATCH4 YY1 ABCA7 SLC40A1 SIRT1 CDKAL1 FAT1 VPS52 PWWP2B HMCN2 CLCNKA TELO2 MTIF2 MACF1 TAF13 KDM1A CDH15 TCTN2 | 1.49e-05 | 1116 | 175 | 18 | 31753913 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.61e-05 | 361 | 175 | 10 | 26167880 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DSC1 DSG1 ELP1 ISOC1 GPATCH4 HNRNPK DHX30 DHX9 PHB1 GUF1 PPP2R1A RBM22 WDR11 ARHGEF1 EIF4A1 MACF1 NIPBL KDM1A RPL9 XPOT | 1.72e-05 | 1353 | 175 | 20 | 29467282 |
| Pubmed | 1.92e-05 | 162 | 175 | 7 | 25826454 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | RAP1GAP GOLM2 DOCK9 SLC10A3 GPATCH4 BCAR1 ADCY3 CASK EPS15L1 SUPT5H ARHGEF1 UNC5C VAMP1 PKD1 DCXR PUS7 | 1.96e-05 | 925 | 175 | 16 | 28986522 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IRS4 DACH1 ELP1 GPATCH4 BCS1L SIRT1 CDKAL1 HNRNPK DHX30 DHX9 CASK PHB1 GUF1 VPS52 MRPL15 TELO2 MTIF2 TMEM131 TRMT61B DCXR CPSF7 | 2.25e-05 | 1496 | 175 | 21 | 32877691 |
| Pubmed | 2.41e-05 | 113 | 175 | 6 | 30352685 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31084931 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 2.52e-05 | 2 | 175 | 2 | 27335120 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 8812470 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 30635602 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 25919862 | ||
| Pubmed | Negative transcriptional regulation of the human periostin gene by YingYang-1 transcription factor. | 2.52e-05 | 2 | 175 | 2 | 21839814 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 25665932 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31658245 | ||
| Pubmed | Gadd45 beta and Gadd45 gamma are critical for regulating autoimmunity. | 2.52e-05 | 2 | 175 | 2 | 16287712 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11559713 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 32779889 | ||
| Pubmed | SIRT1 is transcriptionally repressed by YY1 and suppresses ferroptosis in rheumatoid arthritis. | 2.52e-05 | 2 | 175 | 2 | 36882816 | |
| Pubmed | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | 2.52e-05 | 2 | 175 | 2 | 30706156 | |
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 2.52e-05 | 2 | 175 | 2 | 38069401 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11078829 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 33188786 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 30241936 | ||
| Pubmed | Transient ectopic expression as a method to detect genes conferring drug resistance. | 2.52e-05 | 2 | 175 | 2 | 18324624 | |
| Pubmed | Genomic organization and functional analysis of murine PKD2L1. | 2.52e-05 | 2 | 175 | 2 | 15548533 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18791038 | ||
| Pubmed | A novel mouse desmosomal cadherin family member, desmoglein 1 gamma. | 2.52e-05 | 2 | 175 | 2 | 12631243 | |
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 2.52e-05 | 2 | 175 | 2 | 20805576 | |
| Pubmed | Biochemical insight into pseudouridine synthase 7 (PUS7) as a novel interactor of sirtuin, SIRT1. | 2.52e-05 | 2 | 175 | 2 | 31451225 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 36395406 | ||
| Pubmed | Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells. | 2.52e-05 | 2 | 175 | 2 | 14691480 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 29426960 | ||
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 2.52e-05 | 2 | 175 | 2 | 15044642 | |
| Pubmed | ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. | 2.52e-05 | 2 | 175 | 2 | 32155954 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 36241903 | ||
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 2.52e-05 | 2 | 175 | 2 | 8041726 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 29764467 | ||
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 2.52e-05 | 2 | 175 | 2 | 18648499 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 8823356 | ||
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 2.52e-05 | 2 | 175 | 2 | 8544406 | |
| Pubmed | Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. | 2.52e-05 | 2 | 175 | 2 | 23778143 | |
| Pubmed | Gadd45b and Gadd45g are important for anti-tumor immune responses. | 2.52e-05 | 2 | 175 | 2 | 19688743 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 32389683 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 26749169 | ||
| Pubmed | Assignment of human GADD45G to chromosome 9q22.1-->q22.3 by radiation hybrid mapping. | 2.52e-05 | 2 | 175 | 2 | 10773677 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 24863058 | ||
| Pubmed | ABC proteins protect the human body and maintain optimal health. | 2.52e-05 | 2 | 175 | 2 | 21389634 | |
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 2.52e-05 | 2 | 175 | 2 | 9916798 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9916791 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 28373057 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 36222184 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11120739 | ||
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 2.52e-05 | 2 | 175 | 2 | 32035013 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31302121 | ||
| Pubmed | Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene. | 2.52e-05 | 2 | 175 | 2 | 29616858 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 14570867 | ||
| Pubmed | ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum. | 2.52e-05 | 2 | 175 | 2 | 12673275 | |
| Pubmed | ABCA1 Is Coordinated with ABCB1 in the Arsenic-Resistance of Human Cells. | 2.52e-05 | 2 | 175 | 2 | 29951962 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 38641822 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18003760 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 14769796 | ||
| Pubmed | Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. | 2.52e-05 | 2 | 175 | 2 | 15930518 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16288004 | ||
| Pubmed | Expression of the Abca-subfamily of genes in Abcc6-/- mice--upregulation of Abca4. | 2.52e-05 | 2 | 175 | 2 | 21435020 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21955513 | ||
| Pubmed | Keratin 19 binds and regulates cytoplasmic HNRNPK mRNA targets in triple-negative breast cancer. | 2.52e-05 | 2 | 175 | 2 | 37592256 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11014860 | ||
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 2.55e-05 | 34 | 175 | 4 | 20834067 | |
| Interaction | DEFB135 interactions | 1.35e-06 | 42 | 170 | 6 | int:DEFB135 | |
| Interaction | FBXO2 interactions | COL6A1 GOLM2 ITGA8 LAMA5 ADGRV1 CEMIP2 CEMIP DUOX1 LRIG1 CSPG4 TMEM131 SEMA6A IGSF3 TCTN2 | 1.07e-05 | 411 | 170 | 14 | int:FBXO2 |
| Interaction | RHOF interactions | IRS4 DOCK9 CEMIP2 DHX30 CASK PHB1 EFR3A PPP2R1A FAT1 VPS52 WDR11 TELO2 MACF1 SLC7A5 PLCB3 ATP13A3 IGSF3 XPOT | 1.62e-05 | 673 | 170 | 18 | int:RHOF |
| Interaction | CRKL interactions | 2.38e-05 | 227 | 170 | 10 | int:CRKL | |
| Interaction | RHOQ interactions | IRS4 DOCK9 CEMIP2 ABCB1 CASK EFR3A PPP2R1A FAT1 SLC30A5 WDR11 SLC7A5 SEMA6A ATP13A3 IGSF3 | 2.41e-05 | 442 | 170 | 14 | int:RHOQ |
| Interaction | CDC5L interactions | ELP1 API5 HNRNPK DHX9 PHB1 STAB1 PPP2R1A PARP4 RBM22 VPS52 SUPT5H ARHGEF1 EIF4A1 TRIM55 MACF1 CNOT1 NIPBL KDM1A RPL9 CPSF7 | 3.67e-05 | 855 | 170 | 20 | int:CDC5L |
| Cytoband | 3p21.1 | 1.99e-05 | 42 | 174 | 4 | 3p21.1 | |
| Cytoband | 14q32.33 | 2.48e-04 | 228 | 174 | 6 | 14q32.33 | |
| GeneFamily | ATP binding cassette subfamily A | 1.70e-06 | 14 | 119 | 4 | 805 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.13e-05 | 161 | 119 | 8 | 593 | |
| GeneFamily | Ferlin family | 6.33e-04 | 6 | 119 | 2 | 828 | |
| GeneFamily | Desmosomal cadherins | 8.83e-04 | 7 | 119 | 2 | 1188 | |
| GeneFamily | Fibulins | 1.17e-03 | 8 | 119 | 2 | 556 | |
| GeneFamily | Chloride voltage-gated channels | 1.87e-03 | 10 | 119 | 2 | 302 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 OBSCN NCAM2 ADGRV1 DNAH1 SORCS1 FAT1 HMCN1 NRXN1 DNAH9 | 1.58e-10 | 184 | 172 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 OBSCN NCAM2 ADGRV1 DNAH1 SORCS1 FAT1 HMCN1 NRXN1 DNAH9 | 1.58e-10 | 184 | 172 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 OBSCN NCAM2 ADGRV1 DNAH1 SORCS1 FAT1 HMCN1 NRXN1 DNAH9 | 1.58e-10 | 184 | 172 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CNTN4 COL6A1 COL6A3 OBSCN DACH1 ADCY3 FAT1 CSPG4 UNC5C MOCS1 ADGRD1 | 2.22e-10 | 190 | 172 | 11 | 4eb92aef1ee868f4537483d19014d947b7684612 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CNTN4 COL6A1 COL6A3 OBSCN DACH1 ADCY3 FAT1 CSPG4 UNC5C MOCS1 ADGRD1 | 2.22e-10 | 190 | 172 | 11 | 7be4341e2909101d756f14031c21e705eb45e69a |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | COL6A1 COL6A3 DACH1 ITGA8 NCAM2 GRIK4 SLC40A1 CEMIP HMCN1 UNC5C MOCS1 | 2.63e-10 | 193 | 172 | 11 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | CNTN4 COL6A1 COL6A3 OBSCN DACH1 ADCY3 CSPG4 UNC5C MOCS1 ADGRD1 | 1.36e-09 | 171 | 172 | 10 | 080003f698f867935c2bfc55d241d3650f45a0ab |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL6A1 ABCA1 LAMA5 CHRNA1 CEMIP POSTN PKD1 SNTG1 ATP13A3 CDH15 | 5.07e-09 | 196 | 172 | 10 | b8b9801181d7604871b48aebacb295d0a57a5eaf |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.56e-08 | 173 | 172 | 9 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.00e-08 | 187 | 172 | 9 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 5.48e-08 | 189 | 172 | 9 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.27e-08 | 192 | 172 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.56e-08 | 193 | 172 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.16e-08 | 195 | 172 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.16e-08 | 195 | 172 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.16e-08 | 195 | 172 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | proximal-Epithelial-Ionocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IRS4 DDX12P RXYLT1 CHRNA1 POSTN GADD45G CLCNKA CLCNKB MOV10L1 | 7.82e-08 | 197 | 172 | 9 | f65c35761da7c168d5c6e4d7edf5dafa26652fe4 |
| ToppCell | proximal-Epithelial-Ionocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IRS4 DDX12P RXYLT1 CHRNA1 POSTN GADD45G CLCNKA CLCNKB MOV10L1 | 7.82e-08 | 197 | 172 | 9 | e5d5accefaacea5ed2e22f906f5bcbc75083f287 |
| ToppCell | proximal-3-Epithelial-Ionocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | IRS4 DDX12P RXYLT1 CHRNA1 POSTN GADD45G CLCNKA CLCNKB MOV10L1 | 7.82e-08 | 197 | 172 | 9 | 288492fc67d8e81349d38e82caf1f1890276b299 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.82e-08 | 197 | 172 | 9 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.82e-08 | 197 | 172 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.16e-08 | 198 | 172 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-08 | 200 | 172 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-07 | 160 | 172 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-07 | 160 | 172 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-07 | 170 | 172 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.50e-07 | 171 | 172 | 8 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-07 | 183 | 172 | 8 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 187 | 172 | 8 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 187 | 172 | 8 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.91e-07 | 187 | 172 | 8 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 6.91e-07 | 187 | 172 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 187 | 172 | 8 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.48e-07 | 189 | 172 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.10e-07 | 191 | 172 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-07 | 192 | 172 | 8 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.43e-07 | 192 | 172 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.76e-07 | 193 | 172 | 8 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.76e-07 | 193 | 172 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.76e-07 | 193 | 172 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.76e-07 | 193 | 172 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.11e-07 | 194 | 172 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 9.11e-07 | 194 | 172 | 8 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.11e-07 | 194 | 172 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.11e-07 | 194 | 172 | 8 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.11e-07 | 194 | 172 | 8 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.11e-07 | 194 | 172 | 8 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.11e-07 | 194 | 172 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.47e-07 | 195 | 172 | 8 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.47e-07 | 195 | 172 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.84e-07 | 196 | 172 | 8 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-06 | 197 | 172 | 8 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.02e-06 | 197 | 172 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 197 | 172 | 8 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.02e-06 | 197 | 172 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.02e-06 | 197 | 172 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 198 | 172 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 198 | 172 | 8 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 199 | 172 | 8 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 199 | 172 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.14e-06 | 200 | 172 | 8 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.14e-06 | 200 | 172 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-06 | 200 | 172 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 200 | 172 | 8 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-06 | 200 | 172 | 8 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-06 | 200 | 172 | 8 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 200 | 172 | 8 | 482dfbbd8958b64c31568dccbffe3cc9589f876b | |
| ToppCell | wk_08-11-Mesenchymal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 200 | 172 | 8 | 91416639e69621c5b36eebf061d81bccfe66f135 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-06 | 200 | 172 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-06 | 153 | 172 | 7 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 159 | 172 | 7 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.14e-06 | 161 | 172 | 7 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 169 | 172 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.85e-06 | 172 | 172 | 7 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.24e-06 | 174 | 172 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 175 | 172 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-06 | 177 | 172 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 6.31e-06 | 179 | 172 | 7 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-06 | 179 | 172 | 7 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-06 | 180 | 172 | 7 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-06 | 180 | 172 | 7 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.54e-06 | 180 | 172 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-06 | 181 | 172 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 182 | 172 | 7 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 182 | 172 | 7 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.55e-06 | 184 | 172 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.55e-06 | 184 | 172 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 7.55e-06 | 184 | 172 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 7.82e-06 | 185 | 172 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.10e-06 | 186 | 172 | 7 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.10e-06 | 186 | 172 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.39e-06 | 187 | 172 | 7 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 187 | 172 | 7 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.39e-06 | 187 | 172 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.39e-06 | 187 | 172 | 7 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 187 | 172 | 7 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 187 | 172 | 7 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.39e-06 | 187 | 172 | 7 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | AMFR SLC10A3 YY1 ADCY3 CDKAL1 EPS15L1 F11R SUPT5H VAMP1 PLCB3 | 2.49e-06 | 199 | 169 | 10 | 2135_DN |
| Disease | Disease Exacerbation | AMFR RAP1GAP ABCA13 YY1 ABCA7 ABCC6 ABCB1 PHB1 PPP2R1A KDM1A | 3.57e-08 | 165 | 166 | 10 | C0235874 |
| Disease | Malignant neoplasm of breast | AMFR RAP1GAP ABCA4 HK3 POLH OBSCN ELP1 JAKMIP3 BCAR1 SIRT1 HNRNPK ABCB1 PHB1 SORCS1 CUL5 OTOF MACF1 RASL10B DNAH9 NIPBL | 2.88e-06 | 1074 | 166 | 20 | C0006142 |
| Disease | Bartter syndrome | 3.45e-06 | 6 | 166 | 3 | cv:C0004775 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 2.04e-05 | 10 | 166 | 3 | DOID:12387 (implicated_via_orthology) | |
| Disease | right ventricular ejection fraction measurement | 2.36e-05 | 30 | 166 | 4 | EFO_0021816 | |
| Disease | Bartter disease type 4B | 3.15e-05 | 2 | 166 | 2 | cv:C4310805 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 3.15e-05 | 2 | 166 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 3.15e-05 | 2 | 166 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 3.15e-05 | 2 | 166 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 3.15e-05 | 2 | 166 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 3.15e-05 | 2 | 166 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 3.15e-05 | 2 | 166 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 3.15e-05 | 2 | 166 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 9.40e-05 | 3 | 166 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy | 1.87e-04 | 4 | 166 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 1.87e-04 | 4 | 166 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.87e-04 | 4 | 166 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.87e-04 | 4 | 166 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.87e-04 | 4 | 166 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.87e-04 | 4 | 166 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Bartter Disease | 3.11e-04 | 5 | 166 | 2 | C0004775 | |
| Disease | systemic mastocytosis | 3.67e-04 | 25 | 166 | 3 | MONDO_0016586 | |
| Disease | Bipolar Disorder | CNTN4 ABCA13 DOCK9 GRIK4 ADCY3 ITIH1 SIRT1 STAB1 NRXN1 RIMS1 | 3.91e-04 | 477 | 166 | 10 | C0005586 |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 4.65e-04 | 6 | 166 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 4.71e-04 | 243 | 166 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | urate measurement | ABCA1 NAALADL1 DACH1 ADGRV1 CDKAL1 DNAH1 STAB1 CEMIP SLC12A1 NRXN1 CSPG4 PLCB3 PRKAG2 HEATR5B | 5.63e-04 | 895 | 166 | 14 | EFO_0004531 |
| Disease | intraocular pressure measurement | COL6A1 COL6A3 ABCA1 ABCA4 ISOC1 GRIK4 ADAMTS6 CSPG4 PRKAG2 TRMT61B | 6.47e-04 | 509 | 166 | 10 | EFO_0004695 |
| Disease | Vomiting | 6.49e-04 | 7 | 166 | 2 | C0042963 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 6.49e-04 | 7 | 166 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CNTN4 ABCA1 IRS4 ABCA4 HK3 ABCA13 OBSCN ABCC6 ABCB1 POSTN FAT1 ARHGEF1 | 6.53e-04 | 702 | 166 | 12 | C0009402 |
| Disease | melanoma | 7.49e-04 | 126 | 166 | 5 | EFO_0000756 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 8.61e-04 | 8 | 166 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | COL6A1 COL6A3 LAMA5 NBEA BCAR1 ODF2 PNKD YY1 ITIH1 CDKAL1 LRIG1 PKD1 ANKRD11 NADK SNTG1 PRKAG2 CNOT1 KDM1A | 8.88e-04 | 1392 | 166 | 18 | EFO_0005763 |
| Disease | Kartagener Syndrome | 1.00e-03 | 35 | 166 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.00e-03 | 35 | 166 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.00e-03 | 35 | 166 | 3 | C4317124 | |
| Disease | Colorectal Neoplasms | 1.02e-03 | 277 | 166 | 7 | C0009404 | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 1.10e-03 | 9 | 166 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 1.10e-03 | 9 | 166 | 2 | EFO_0004606 | |
| Disease | retinal degeneration (is_implicated_in) | 1.10e-03 | 9 | 166 | 2 | DOID:8466 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.73e-03 | 152 | 166 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.91e-03 | 93 | 166 | 4 | C1535926 | |
| Disease | waist-hip ratio, body mass index | 2.00e-03 | 12 | 166 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | amygdala volume | 2.36e-03 | 13 | 166 | 2 | EFO_0006934 | |
| Disease | Primary Ciliary Dyskinesia | 2.36e-03 | 47 | 166 | 3 | C4551720 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.74e-03 | 14 | 166 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 16:1 measurement | 2.74e-03 | 14 | 166 | 2 | EFO_0010358 | |
| Disease | glycerate measurement | 3.15e-03 | 15 | 166 | 2 | EFO_0021029 | |
| Disease | Ciliopathies | 3.51e-03 | 110 | 166 | 4 | C4277690 | |
| Disease | Age-related macular degeneration | 4.54e-03 | 18 | 166 | 2 | cv:C0242383 | |
| Disease | hematocrit | ADGRV1 SLC40A1 ABCC6 CDKAL1 PHB1 STAB1 FAT1 GADD45G CLCNKB SLC7A5 PLCB3 PRKAG2 TRMT61B | 4.84e-03 | 1011 | 166 | 13 | EFO_0004348 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.84e-03 | 276 | 166 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 4.92e-03 | 194 | 166 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | neuropsychological test | 5.24e-03 | 197 | 166 | 5 | EFO_0003926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNEVIGIRQLSQSLL | 391 | P30153 | |
| EQSIQAGRVQLETII | 516 | Q9UBC2 | |
| RLVVVNEADSIVGII | 531 | Q9UGJ0 | |
| QEVREQRVTGVLIAS | 1076 | P48751 | |
| EVVQSQQVAVGRQLE | 141 | Q92888 | |
| QTREVIQQTLAAIVD | 2406 | Q6UB99 | |
| GIVQLRILRTQEAII | 706 | Q93034 | |
| VENLALEVQVGQEIL | 756 | Q6UVK1 | |
| NVIVSIIREGRAVVL | 2111 | P78363 | |
| LEVAVEALARLQQGV | 456 | P56945 | |
| VNIGILIAVTRVISQ | 726 | Q6QNK2 | |
| NSILNEVQVGVIIIE | 431 | Q9H7F0 | |
| ILIQRQIDVDTVFEV | 36 | Q9Y574 | |
| VVLQQGLADRIVRDV | 191 | Q9Y276 | |
| LQDVVEQAIIRVLTG | 596 | O95477 | |
| RDEQSAVIVVIQALN | 4211 | Q8WXG9 | |
| RIQIEQGTLNITIVN | 361 | Q8IWV2 | |
| IERAIILVQTGQEAL | 3531 | Q86UQ4 | |
| TVSGRQQLVELVAEQ | 206 | Q9BZZ5 | |
| AVILLQEIGVLDQRE | 851 | Q7L2E3 | |
| VVCNVEQVRILRGLG | 241 | Q9UI36 | |
| IQVVVIDGNQGRVVS | 1246 | Q8WUJ3 | |
| RAGIIQVLLEAVAIA | 311 | Q14156 | |
| VINDVINDRFVGRVI | 336 | Q9UN42 | |
| LGNVVNIIVARLIVL | 291 | Q9UKP5 | |
| ERVVQGATQGDVLVL | 1781 | Q8IZY2 | |
| QTRVLGVENLRVVDA | 531 | Q8NE62 | |
| AGELITQRELVSRQV | 136 | P35232 | |
| GEIRTITVVQRQQCA | 256 | Q9NW64 | |
| RNVVGVLLVFDVTNR | 86 | Q8N4Z0 | |
| IVIGLILRESSIINQ | 1281 | Q4ADV7 | |
| QQLIQVIRSIGVYDV | 96 | Q8N684 | |
| ILLNGNTVEELVTVV | 556 | Q8N442 | |
| INVRFLREIIGVVSQ | 461 | P08183 | |
| RQVVEVTVGLQLIQL | 46 | P02708 | |
| VTVGLQLIQLINVDE | 51 | P02708 | |
| EIRNTTLQDVLVAVI | 531 | Q9NRD9 | |
| DIEEIIGVRILNVFQ | 3721 | Q14517 | |
| IREINGISVANQTVE | 536 | O14936 | |
| ANIAIVGNVRLVGEV | 281 | P58400 | |
| IQQTALELVGRGVEV | 216 | Q96CN7 | |
| ILGATIENSRIVLQI | 141 | P08727 | |
| VALLRGVQCQVQLVE | 11 | P0DP03 | |
| TSRVLLNVGQEVIAV | 66 | Q9BXT6 | |
| QLLVVQNVVAEDAGR | 746 | Q96JA1 | |
| QIVDRAIQVVRSALA | 356 | O60524 | |
| ARGAQVTDIVVLVVA | 246 | P46199 | |
| DQAVLRQDGVVVTIN | 766 | P19827 | |
| QELRVATERGLVIVN | 281 | Q86U10 | |
| VALLRGVQCQVQLVE | 11 | P0DP02 | |
| TVSVDGRVLRIEQAQ | 1941 | Q8NDA2 | |
| ELIQQIVAAINAGII | 116 | O95069 | |
| LVVETGQDGVQIRSL | 76 | Q5T3I0 | |
| LLARGIDVQQVSLVI | 331 | P60842 | |
| QVIEGNAAVVLRSRL | 226 | O95544 | |
| LQRNITLLNGVAIIV | 46 | Q8MH63 | |
| VAQRRTVSIEVGVQN | 411 | P09131 | |
| VIQVSQIVARGLIAR | 111 | Q7Z4W1 | |
| QILRVLGENAIAVRT | 1776 | Q6KC79 | |
| NEEQVVVIQARTVLT | 671 | Q5VZ66 | |
| SIEINVITAQELRGI | 146 | Q8IV20 | |
| VITAQELRGIQNEIE | 151 | Q8IV20 | |
| LQRNITLLNGVAIIV | 46 | Q01650 | |
| ILQQLVTLNEGIEAV | 76 | Q96LR2 | |
| VAVIDGNRVLVTVFR | 391 | O95163 | |
| ATVVRQGLVDRAQQL | 2551 | O15230 | |
| ANIAIVGNVRLVGEV | 1286 | Q9ULB1 | |
| VLQIFRVGRVNETTE | 411 | Q9UKK3 | |
| AITRRQAVELNVVAI | 646 | P52790 | |
| LVVVEVNSEFRIQVR | 16 | Q02413 | |
| SLQINITAVAQVEIR | 776 | P53708 | |
| AVQEGLIDRQVTVRL | 1756 | Q9UPN3 | |
| VDIVAQLQRLEGLRT | 136 | Q9NZB8 | |
| LLAAGQVIRIVRAQV | 3391 | Q96RW7 | |
| QVIRIVRAQVSDVAV | 3396 | Q96RW7 | |
| LLGAVVQVEIRVNDV | 146 | Q6V1P9 | |
| GQLEVEVIRARSLTQ | 1551 | Q86UR5 | |
| EQSITIVRGLQDVTV | 2376 | Q5VST9 | |
| TEVIVDGIVANALRV | 716 | Q01970 | |
| TQGLLAQEVREVVLT | 771 | Q9P2D7 | |
| NRIDIEVLSVVAQQI | 1636 | Q9P2D7 | |
| LAVLGVVSAQRQVTV | 11 | O75054 | |
| SVQLLVTGVVQQIVR | 1656 | Q9P2D3 | |
| VSLGQALEVVIQLQE | 406 | O60341 | |
| QLSLQIGDVVRIQET | 26 | Q92608 | |
| RATQEEVAVNVTRVI | 881 | Q9BZ29 | |
| GIEIFVVVVGRQVNE | 966 | P12109 | |
| EVVTEVLTVGQVQRG | 41 | I3L3R5 | |
| VDQQRLVRSLIAVGL | 31 | Q9Y5T4 | |
| DLQRLLVTVAGQVVS | 4906 | Q9Y6R7 | |
| GLSIIGVQQIDRVVE | 151 | Q5VV42 | |
| LLVAAQRQDRLTVGV | 26 | O75293 | |
| DIVRVGDVQRLAAIV | 91 | O95257 | |
| GVQVVIEELRQLGAA | 151 | Q9H972 | |
| SQVVVIRQERAGQTS | 441 | P29322 | |
| ILTEELQAIRQAIQG | 606 | Q4G0X9 | |
| VLAREVGEDINVQQL | 241 | Q8IYE1 | |
| VIQRLEIGQDLIQVA | 471 | P12111 | |
| VQRVVESLDVGQDRV | 1051 | P12111 | |
| FRQLGTVQQVISERV | 1191 | P12111 | |
| QAAGIRLQDQVVIID | 381 | A8MPP1 | |
| TRQAAGIRLQDQVVI | 396 | Q92771 | |
| GNIQVVEETQVILRE | 1081 | O60266 | |
| GDLVAIVTQLEQVSR | 921 | Q9P2S6 | |
| GILTRNIVIQGEVED | 486 | Q9UHN6 | |
| VALLRGVQCQVQLVE | 11 | P01768 | |
| VNRQVILQVGVINEA | 426 | Q08554 | |
| GTQLSQVEILQRVID | 61 | Q02535 | |
| IQIAAALGLRTINVV | 201 | Q9BV79 | |
| QIIEQALEAGAVVLI | 3496 | Q9NYC9 | |
| VTAVQELNRSQEIGV | 316 | Q16099 | |
| VRVEQVVNGALVVTV | 11 | Q6NUJ5 | |
| SVDVNNVVLILNGRE | 156 | Q9Y2B1 | |
| IRTVQVGLDREVVAV | 211 | P55291 | |
| EILEAISQNSVVIIR | 396 | Q08211 | |
| AQRRQTLQEGGVVVL | 636 | Q8NAC3 | |
| VSITVIEARQLVGLN | 256 | Q9HC10 | |
| AQVRIVVLEAVSGLQ | 1961 | P98161 | |
| IVQAVLRIQSAEGQR | 221 | Q9GZK3 | |
| VALLRGVQCQVQLVE | 11 | P01772 | |
| EIIVLNDRVTDLVNQ | 461 | Q5BJF6 | |
| AVERNVGVIVAAVLV | 231 | Q9Y624 | |
| VRLNTEVASVVVQLL | 266 | O14654 | |
| GVLLVVIARLNLNEV | 81 | Q9NZG7 | |
| AITITEARQLVGENI | 86 | Q2WGJ9 | |
| VAELQGQVQRTEVAR | 46 | Q6P4E1 | |
| IRQQILETRVIGTSE | 106 | Q96S79 | |
| TRQVQIEGETLALQV | 71 | Q9BPW5 | |
| VNVLGTDVVRQSILR | 131 | Q8TDW5 | |
| QTQAQVEEVVDIIRV | 36 | P23763 | |
| QDVVSVGRLQIRALA | 211 | Q8N490 | |
| IDLTQLVNGRGVTIQ | 116 | Q9P015 | |
| RAVTELTVIQRDVQA | 426 | Q6IEE7 | |
| SGVQDAINIRDVLIQ | 1066 | Q8NDG6 | |
| RRIALGNNVSINIEV | 226 | Q9NW38 | |
| VGDVVNLVSVDVQRL | 406 | O95255 | |
| VVQVLRNAGEEVTLT | 121 | Q9NSN8 | |
| EDRIITITGTQDQIQ | 431 | P61978 | |
| VLIGLIQVGEVSNRD | 76 | Q8NFP9 | |
| LVGNLLALVVIVQNR | 46 | P32249 | |
| TVVLRNITGTDDQVQ | 346 | Q96PZ0 | |
| RRSSAIGIENIQEVQ | 496 | P47736 | |
| VVLVALRDINQGEEL | 276 | Q8NE22 | |
| NIDTLEQVAGIQRII | 346 | Q96EB6 | |
| VIVRISQGFDISQVL | 811 | Q13621 | |
| RLLGEEVVRVLQAVV | 186 | Q9Y4R8 | |
| EVVRVLQAVVDSLQG | 191 | Q9Y4R8 | |
| VTQLLQENVIESERG | 476 | Q9NP59 | |
| RVATQLVVSIRVQGD | 361 | Q9Y253 | |
| TVGVIVRLERETFQV | 546 | O00267 | |
| VQEVSQLFRSVLQEV | 111 | Q7Z3Z2 | |
| GRQGRVQVEDIVFLI | 76 | Q15543 | |
| VVQEVQQVLSEFIRA | 121 | Q6P9B9 | |
| RQEILVQVIGTLELV | 1026 | P20701 | |
| QVRSNNEAIRVGILT | 321 | Q7Z745 | |
| VEITTDNILEGRIQV | 486 | Q9UKV5 | |
| ESQILVGIVQRAQLV | 586 | P51800 | |
| ESQILVGIVRRAQLV | 586 | P51801 | |
| IIVQFGVREVTAAQV | 276 | A5YKK6 | |
| LGQLQVEVENFVLRV | 536 | Q8N1B4 | |
| IAELVNVLQERVGEL | 46 | Q6ZYL4 | |
| IAILVGSNDRVQGVI | 176 | Q9BYV6 | |
| VNITQVIELLDGIRT | 361 | Q9BVS5 | |
| IISTQRVVVQKEGVR | 61 | O15394 | |
| AINTGILEVDQILIV | 481 | Q9UHI7 | |
| INVVIQENGSLVEIR | 101 | P32969 | |
| LQAVTDVIRINGRDV | 296 | Q9H2E6 | |
| QEVILVQTREEVVGG | 101 | P25490 | |
| IELVAVERGNRTTII | 591 | Q92545 | |
| GILQQLLRQEVEGLV | 436 | Q12815 | |
| QVLAVNISEEGRILL | 601 | Q9NY15 | |
| TRRVLQLETVLEGVV | 711 | Q9P0L9 | |
| NQGAENVERVLVTVI | 816 | O43592 | |
| NVERVLVTVIQGAVE | 821 | O43592 | |
| VLEQRIVQQVTGILK | 701 | Q8TAD4 | |
| LGGRVVNVAQIIELV | 201 | Q9H598 | |
| AQRAELVAVITVLQD | 496 | Q9WJR5 | |
| REILILDLEVNQTVG | 266 | Q9BZH6 | |
| QIATNGVVHVIDRVL | 216 | Q15063 | |
| VQLEEGDVQRTLIQV | 821 | Q8WY21 | |
| GLIVREVSIEISRQQ | 116 | O95185 | |
| VEGITQQEILGVETR | 576 | Q96GX1 | |
| VRLRVASLELQGNVI | 231 | A6NMB1 | |
| VQRQLSIVVTALEGA | 716 | Q9UQQ1 |